Amber Biolife Overview

  • Founded
  • 2014
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Corporate
  • Financing Rounds
  • 1

Amber Biolife General Information


Developer of biologic therapeutic products. The company p is focused on the development and commercialization of a novel processed human platelet lysate technology (Aurarix) as a stem cell growth supplement (UltraGro Advanced) and as a biologic eye drop for dry eye syndrome (Elate Ocular).

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Industries
Zheng Yang Biomedical Technology Company
Primary Office
  • Seattle, WA
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amber Biolife Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Amber Biolife‘s full profile, request access.

Request a free trial